Crestone, Inc. ("Crestone") today announced recent publication in the leading infectious disease journal, The Lancet Infectious Diseases, of positive results from a Phase 2 clinical trial evaluating ...

Canada: Researchers have found in a new randomized clinical trial that a 4-week vancomycin pulse and taper regimen showed a ...

Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Acurx's Program in the Broader CDI Patient Population is Ready to Advance toPhase 3 International Clinical Trials Acurx is launching a ground-breaking clinical trial ...

Thrombocytopenia is a rare side effect of vancomycin, an antibiotic that is often used to treat Gram-positive bacterial infections. A 67-year-old man developed bilateral pulmonary emboli and ...

AIMS To design and evaluate dosing guidelines for vancomycin based on data collected during routine use of the drug. METHODS Following the observation that 66% of neonatal vancomycin trough ...

Center for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, Texas 77030-2707, United States Reproductive Biology and Gynaecological Oncology Group, Swansea University ...

Antibiotics previously thought to help people with cirrhosis manage the risk of hepatic encephalopathy do not appear to benefit the condition. These antibiotics possibly cause more side effects than ...

Indian researchers from the National Centre for Cell Science have identified a unique red bacterium in Antarctica, capable of withstanding intense UV radiation.